|1.||Marte, Filippo: 16 articles (04/2012 - 02/2009)|
|2.||Patanè, Salvatore: 16 articles (04/2012 - 02/2009)|
|3.||Iervasi, Giorgio: 14 articles (11/2014 - 11/2004)|
|4.||Pingitore, Alessandro: 8 articles (08/2013 - 02/2005)|
|5.||Botella-Carretero, José I: 7 articles (01/2015 - 06/2004)|
|6.||Escobar-Morreale, Héctor F: 7 articles (01/2015 - 06/2004)|
|7.||Danzi, Sara: 6 articles (07/2012 - 06/2002)|
|8.||Klein, Irwin: 6 articles (07/2012 - 06/2002)|
|9.||Nygaard, Birte: 5 articles (01/2015 - 01/2008)|
|10.||Nogueira, Célia Regina: 5 articles (08/2014 - 10/2009)|
01/01/1956 - "Response to triiodothyronine as index of persistence of disease in the thyroid remnant of patients in remission from hyperthyroidism."
01/01/2013 - "A comparative genotoxicity study of a supraphysiological dose of triiodothyronine (T₃) in obese rats subjected to either calorie-restricted diet or hyperthyroidism."
06/01/1984 - "In this study, hypo- and hyperthyroidism were induced by 6-n-propyl-2-thiouracil (PTU) and triiodothyronine (T3) respectively. "
10/15/2013 - "Subclinical hyperthyroidism is defined as a low TSH with both FT4 and free triiodothyronine (FT3) concentrations within range (2.6-5.7 pmol/l). "
02/15/2013 - "Hyperthyroidism was induced by administration of triiodothyronine (T3; 300μg/kg, i.p., for 12 weeks in T3 group). "
|2.||Graves Disease (Basedow Disease)
06/01/1965 - "[Test of inhibition of thyroid uptake of radioiodine by means of triiodothyronine in patients with Basedow's disease in clinical remission]."
06/01/1996 - "Prospective, randomized trial of patients with Graves' disease followed for 3 months after the initiation of therapy with an antithyroid drug and combined with the later addition of triiodothyronine to keep the patient euthyroid. "
01/01/1978 - "[Critical study of the value of serum triiodothyronine (T3) determination in Basedow's disease]."
06/01/2015 - "To assess in a pediatric population, the clinical characteristics and management of triiodothyronine-predominant Graves' disease (T3-P-GD), a rare condition well known in adults, but not previously described in children. "
06/01/2015 - "Triiodothyronine-predominant Graves' disease in childhood: detection and therapeutic implications."
05/12/2013 - "Recently, several studies suggested to complete it with l-triiodothyronine in acquired hypothyroidism. "
04/01/2000 - "The objective of this study was to test the hypothesis that hypothyroidism [absence of triiodothyronine (-T(3))] and mechanical overload (OV) would convert the plantaris (Plan) muscle from a fast- to a slow-twitch muscle. "
02/13/1980 - "Clinical and biochemical indices of thyroid function were compared in 18 euthyroid control subjects and 54 patients at risk of developing hypothyroidism, and the assessment repeated after a four-week trial of oral triiodothyronine (T3) 40 microgram daily. "
04/01/1960 - "Triiodothyronine in the dog nosis and treatment of hypothyroidism: failure to demonstrate the metabolic insufficiency syndrome (controlled study)."
03/01/1958 - "However, the occasional improvement, sometimes dramatic, suggested that a therapeutic trial with triiodothyronine in difficult or unresponsive cases of hypometabolism or hypothyroidism is justified."
01/01/2015 - "Iatrogenic thyrotoxicosis secondary to compounded liothyronine."
01/01/2014 - "Thyroid ultrasound revealed well-defined hypoechogenic clusters in both lobes and laboratorial thyrotoxicosis but low triiodothyronine concentration. "
04/01/2007 - "Case history: thyrotoxicosis factitia secondary to triiodothyronine acquired electronically from abroad."
02/01/1999 - "The results indicate that some of bone and mineral markers change rapidly in response to triiodothyronine-induced acute thyrotoxicosis, but the manner of change is not the same as that of chronic thyrotoxicosis."
11/01/1993 - "Thyrotoxicosis in a depressed patient on L-triiodothyronine."
|5.||Body Weight (Weight, Body)
12/01/2015 - "TH induction was evaluated in two ways: 1) in vivo through interperitoneal injection of 10pmol/g body weight of 3,3', 5-triiodothyronine (T3) into premetamorphic tadpoles and analysis after 48h, and 2) in serum-free organ culture in the presence of 10nM T3 after 48h. "
06/01/2015 - "injection of triiodothyronine (at 2 mg/kg of body weight) during 5 days. "
01/01/2015 - "Male Wistar rats were treated for 10 days with triiodothyronine (T3) at a dose of 50µg/100g of body weight. "
01/01/2014 - "From the LI group, we randomly selected 15 mice and injected triiodothyronine (T3, 100 µg/kg body weight per day) intraperitoneally for 24, 48 or 72 hours (5 mice for each time-point). "
01/01/2012 - "Effects of manipulating hypothalamic triiodothyronine concentrations on seasonal body weight and torpor cycles in Siberian hamsters."
|2.||Thyrotropin (Thyroid-Stimulating Hormone)
|10.||Thyrotropin-Releasing Hormone (Protirelin)
|1.||Cardiopulmonary Bypass (Heart-Lung Bypass)
|2.||Drug Therapy (Chemotherapy)
|3.||Coronary Artery Bypass (Coronary Artery Bypass Surgery)
|5.||Renal Dialysis (Hemodialysis)